ChromDesign is an innovative and interdisciplinary network of 10 European academic and private institutions. Our aim is to characterise how 3D chromatin organisation affects gene regulation during cellular differentiation and in several human disorders. ChromDesign’s main focus is to investigate...

Patients with a rare disease generally go through a long and arduous process, sometimes lasting ten or fifteen years (also known as the rare disease odyssey), before finding a physician who knows what is wrong with them. Scientific advances can also take a long time, as it is difficult to find...

SPIDIA4P is a 48-month project funded by the European Commission under de H2020 program that brings together key experts of 19 stakeholder organisations, with the needed critical mass in knowledge on pre-analytical and analytical procedures, on European and international standardisation...

The B-CAST project (Breast CAncer STratification) is coordinated by the Netherlands Cancer Institute Antoni Van Leeuwenhoek and it will be conducted over five years (until September 2020). Breast tumours are heterogeneous, and result from the complex interplay of multiple lifestyle/environmental...

From September 2015, ‘ELIXIR-EXCELERATE’ is facilitating the integration of Europe’s bioinformatics resources, supporting all sectors of life-science R&D. It will deliver excellence to ELIXIR’s users by fast-tracking the development and deployment of essential data services. EXCELERATE funding...

The International Cancer Genome Consortium is an international effort to establish a comprehensive descriptionof genomic, transcriptomic and epigenomic changes in50 different tumor types and/or subtypes which are of clinical and societal importance across the globe. Spain’scontribution to the ICGC...